Endothelial progenitor cells: Current development of their paracrine factors in cardiovascular therapy

Journal of Cardiovascular Pharmacology

Volumn 59, Issue 4, 2012, Pages 387-396

  Xu, Shengjie ^a   Zhu, Junhui ^a   Yu, Lu ^a   Fu, Guosheng ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

beneficial effects; clinical application; endothelial progenitor cells; paracrine factors

Indexed keywords

CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CYTOKINE; FIBROBLAST GROWTH FACTOR; GELATINASE A; GELATINASE B; GROWTH FACTOR; INTERLEUKIN 8; INTERLEUKIN 8 RECEPTOR; KERATINOCYTE GROWTH FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLATELET DERIVED GROWTH FACTOR; SCATTER FACTOR; SOMATOMEDIN; STROMAL CELL DERIVED FACTOR 1; THROMBOPLASTIN; VASCULOTROPIN;

ANGIOGENESIS; CARDIOVASCULAR SYSTEM; CELL COUNT; CELL POPULATION; CYTOKINE RELEASE; ENDOTHELIAL PROGENITOR CELL; HEART PROTECTION; HEART VENTRICLE REMODELING; HUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; REVIEW;

ANIMALS; CARDIOVASCULAR DISEASES; ENDOTHELIAL CELLS; HUMANS; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; PARACRINE COMMUNICATION; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 84859926278     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3182440338     Document Type: Review

References (114)

1. Beltrami AP, Urbanek K, Kajstura J, et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med. 2001;344: 1750-1757. (Pubitemid 32497029)
2. Terrovitis JV, Smith RR, Marban E. Assessment and optimization of cell engraftment after transplantation into the heart. Circ Res. 2010;106: 479-494.
3. Penn MS, Mangi AA. Genetic enhancement of stem cell engraftment, survival, and efficacy. Circ Res. 2008;102:1471-1482.
4. Kamihata H, Matsubara H, Nishiue T, et al. Improvement of collateral perfusion and regional function by implantation of peripheral blood mononuclear cells into ischemic hibernating myocardium. Arterioscler Thromb Vasc Biol. 2002;22:1804-1810. (Pubitemid 35315765)
5. Shumiya T, Shibata R, Shimizu Y, et al. Evidence for the therapeutic potential of ex vivo expanded human endothelial progenitor cells using autologous serum. Circ J. 2010;74:1006-1013.
6. Vasa M, Fichtlscherer S, Aicher A, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001;89:E1-E7.
7. Herbrig K, Gebler K, Oelschlaegel U, et al. Kidney transplantation substantially improves endothelial progenitor cell dysfunction in patients with end-stage renal disease. Am J Transplant. 2006;6:2922-2928.
8. Zhu J, Wang X, Chen J, et al. Reduced number and activity of circulating endothelial progenitor cells from patients with hyperhomocysteinemia. Arch Med Res. 2006;37:484-489.
9. Junhui Z, Xingxiang W, Guosheng F, et al. Reduced number and activity of circulating endothelial progenitor cells in patients with idiopathic pulmonary arterial hypertension. Respir Med. 2008;102:1073-1079.
10. Ma N, Stamm C, Kaminski A, et al. Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid-mice. Cardiovasc Res. 2005;66:45-54. (Pubitemid 40357867)
11. Urbich C, Aicher A, Heeschen C, et al. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol. 2005;39: 733-742. (Pubitemid 41464410)
12. Krenning G, van Luyn MJ, Harmsen MC. Endothelial progenitor cellbased neovascularization: implications for therapy. Trends Mol Med. 2009;15:180-189.
13. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964-967. (Pubitemid 27087709)
14. Kawamoto A, Asahara T, Losordo DW. Transplantation of endothelial progenitor cells for therapeutic neovascularization. Cardiovasc Radiat Med. 2002;3:221-225. (Pubitemid 37329397)
15. Asahara T, Kawamoto A. Endothelial progenitor cells for postnatal vasculogenesis. Am J Physiol Cell Physiol. 2004;287:C572-C579. (Pubitemid 39095841)
16. Dimmeler S, Zeiher AM. Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis? J Mol Med (Berl). 2004;82:671-677. (Pubitemid 39468491)
17. Ward MR, Stewart DJ, Kutryk MJ. Endothelial progenitor cell therapy for the treatment of coronary disease, acute MI, and pulmonary arterial hypertension: current perspectives. Catheter Cardiovasc Interv. 2007; 70:983-998.
18. Jung KH, Roh JK. Circulating endothelial progenitor cells in cerebrovascular disease. J Clin Neurol. 2008;4:139-147.
19. Jujo K, Ii M, Losordo DW. Endothelial progenitor cells in neovascularization of infarcted myocardium. J Mol Cell Cardiol. 2008;45: 530-544.
20. Hirschi KK, Ingram DA, Yoder MC. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol. 2008;28:1584-1595.
21. Yoder MC, Mead LE, Prater D, et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood. 2007;109:1801-1809. (Pubitemid 46348173)
22. Hristov M, Weber C. Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. J Cell Mol Med. 2004;8:498-508. (Pubitemid 44145482)
23. Krenning G, van der Strate BW, Schipper M, et al. CD34+ cells augment endothelial cell differentiation of CD14+ endothelial progenitor cells in vitro. J Cell Mol Med. 2009;13:2521-2533.
24. Rehman J, Li J, Orschell CM, et al. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation. 2003;107:1164-1169. (Pubitemid 36297209)
25. Popa ER, Harmsen MC, Tio RA, et al. Circulating CD34+ progenitor cells modulate host angiogenesis and inflammation in vivo. J Mol Cell Cardiol. 2006;41:86-96. (Pubitemid 43964934)
26. van der Strate BW, Popa ER, Schipper M, et al. Circulating human CD34+ progenitor cells modulate neovascularization and inflammation in a nude mouse model. J Mol Cell Cardiol. 2007;42: 1086-1097. (Pubitemid 46839110)
27. Ingram DA, Mead LE, Tanaka H, et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood. 2004;104:2752-2760. (Pubitemid 39434958)
28. Prater DN, Case J, Ingram DA, et al. Working hypothesis to redefine endothelial progenitor cells. Leukemia. 2007;21:1141-1149. (Pubitemid 46831802)
29. Fan CL, Li Y, Gao PJ, et al. Differentiation of endothelial progenitor cells from human umbilical cord blood CD34+ cells in vitro. Acta Pharmacol Sin. 2003;24:212-218. (Pubitemid 36286006)
30. Griese DP, Ehsan A, Melo LG, et al. Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation. 2003;108:2710-2715. (Pubitemid 37466815)
31. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 1999;85: 221-228. (Pubitemid 29377293)
32. Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A. 2000;97:3422-3427. (Pubitemid 30183318)
33. Murohara T, Ikeda H, Duan J, et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest. 2000;105:1527-1536. (Pubitemid 30390303)
34. Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med. 2001;7:430-436. (Pubitemid 32298545)
35. Sondergaard CS, Bonde J, Dagnaes-Hansen F, et al. Minimal engraftment of human CD34+ cells mobilized from healthy donors in the infarcted heart of athymic nude rats. Stem Cells Dev. 2009;18:845-856.
36. Urbich C, Heeschen C, Aicher A, et al. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation. 2003;108:2511-2516. (Pubitemid 37444414)
37. Aicher A, Heeschen C, Mildner-Rihm C, et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med. 2003;9:1370-1376. (Pubitemid 37466185)
38. Machein MR, Renninger S, de Lima-Hahn E, et al. Minor contribution of bone marrow-derived endothelial progenitors to the vascularization of murine gliomas. Brain Pathol. 2003;13:582-597. (Pubitemid 37420701)
39. Gothert JR, Gustin SE, van Eekelen JA, et al. Genetically tagging endothelial cells in vivo: bone marrow-derived cells do not contribute to tumor endothelium. Blood. 2004;104:1769-1777. (Pubitemid 39202286)
40. Purhonen S, Palm J, Rossi D, et al. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc Natl Acad Sci U S A. 2008;105: 6620-6625. (Pubitemid 351754556)
41. Hur J, Yoon CH, Kim HS, et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol. 2004;24:288-293. (Pubitemid 38197580)
42. Fadini GP, Baesso I, Albiero M, et al. Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. Atherosclerosis. 2008;197:496-503.
43. Tiwari A, Hamilton G, Seifalian AM, et al. Regarding 'Isolation of endothelial cells and their progenitor cells from human peripheral blood'. J Vasc Surg. 2002;35:827; author reply 827-828.
44. Iwaguro H, Yamaguchi J, Kalka C, et al. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation. 2002;105:732-738. (Pubitemid 34157378)
45. Badorff C, Brandes RP, Popp R, et al. Transdifferentiation of bloodderived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation. 2003;107:1024-1032. (Pubitemid 36258727)
46. Iohara K, Zheng L, Wake H, et al. A novel stem cell source for vasculogenesis in ischemia: subfraction of side population cells from dental pulp. Stem Cells. 2008;26:2408-2418.
47. Wang CH, Cherng WJ, Yang NI, et al. Late-outgrowth endothelial cells attenuate intimal hyperplasia contributed by mesenchymal stem cells after vascular injury. Arterioscler Thromb Vasc Biol. 2008;28: 54-60.
48. Doyle B, Sorajja P, Hynes B, et al. Progenitor cell therapy in a porcine acute myocardial infarction model induces cardiac hypertrophy, mediated by paracrine secretion of cardiotrophic factors including TGFbeta1. Stem Cells Dev. 2008;17:941-951.
49. Edelberg JM, Tang L, Hattori K, et al. Young adult bone marrowderived endothelial precursor cells restore aging-impaired cardiac angiogenic function. Circ Res. 2002;90:E89-E93.
50. Di Santo S, Yang Z, Wyler von BallmoosM, et al. Novel cell-free strategy for therapeutic angiogenesis: in vitro generated conditioned medium can replace progenitor cell transplantation. PLoS One. 2009;4:e5643.
51. Barcelos LS, Duplaa C, Krankel N, et al. Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling. Circ Res. 2009; 104:1095-1102.
52. He T, Smith LA, Harrington S, et al. Transplantation of circulating endothelial progenitor cells restores endothelial function of denuded rabbit carotid arteries. Stroke. 2004;35:2378-2384. (Pubitemid 39311267)
53. Pula G, Mayr U, Evans C, et al. Proteomics identifies thymidine phosphorylase as a key regulator of the angiogenic potential of colonyforming units and endothelial progenitor cell cultures. Circ Res. 2009; 104:32-40.
54. Qiao W, Niu L, Liu Z, et al. Endothelial nitric oxide synthase as a marker for human endothelial progenitor cells. Tohoku J Exp Med. 2010;221:19-27.
55. Yang Z, von Ballmoos MW, Faessler D, et al. Paracrine factors secreted by endothelial progenitor cells prevent oxidative stress-induced apoptosis of mature endothelial cells. Atherosclerosis. 2010;211:103-109.
56. Hemmen K, Reinl T, Buttler K, et al. High-resolution mass spectrometric analysis of the secretome from mouse lung endothelial progenitor cells. Angiogenesis. 2011;14:163-172.
57. He T, Peterson TE, Katusic ZS. Paracrine mitogenic effect of human endothelial progenitor cells: role of interleukin-8. Am J Physiol Heart Circ Physiol. 2005;289:H968-H972. (Pubitemid 41129416)
58. Xia L, Fu GS, Yang JX, et al. Endothelial progenitor cells may inhibit apoptosis of pulmonary microvascular endothelial cells: new insights into cell therapy for pulmonary arterial hypertension. Cytotherapy. 2009;11:492-502.
59. Meng F, Liu L, Chin PC, et al. Akt is a downstream target of NF-kappa B. J Biol Chem. 2002;277:29674-29680.
60. Wyler von Ballmoos M, Yang Z, Volzmann J, et al. Endothelial progenitor cells induce a phenotype shift in differentiated endothelial cells towards PDGF/PDGFRbeta axis-mediated angiogenesis. PLoS One. 2010;5:e14107.
61. Gavard J, Gutkind JS. VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol. 2006;8:1223-1234. (Pubitemid 44660587)
62. Hirase T, Kawashima S, Wong EY, et al. Regulation of tight junction permeability and occludin phosphorylation by Rhoa-p160ROCKdependent and -independent mechanisms. J Biol Chem. 2001;276: 10423-10431.
63. Stamatovic SM, Dimitrijevic OB, Keep RF, et al. Protein kinase Calpha- RhoA cross-talk in CCL2-induced alterations in brain endothelial permeability. J Biol Chem. 2006;281:8379-8388. (Pubitemid 43847939)
64. Medina RJ, O'Neill CL, O'Doherty TM, et al. Myeloid angiogenic cells act as alternative M2 macrophages and modulate angiogenesis through IL-8. Mol Med. 2011;17:1045-1055.
65. Santhanam AV, Smith LA, He T, et al. Endothelial progenitor cells stimulate cerebrovascular production of prostacyclin by paracrine activation of cyclooxygenase-2. Circ Res. 2007;100:1379-1388. (Pubitemid 46742928)
66. Fang L, Chen MF, Xiao ZL, et al. Calcitonin gene-related peptide released from endothelial progenitor cells inhibits the proliferation of rat vascular smooth muscle cells induced by angiotensin II. Mol Cell Biochem. 2011;355:99-108.
67. Sieminski AL, Hebbel RP, Gooch KJ. Improved microvascular network in vitro by human blood outgrowth endothelial cells relative to vesselderived endothelial cells. Tissue Eng. 2005;11:1332-1345. (Pubitemid 41636420)
68. Yoon CH, Hur J, Park KW, et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation. 2005;112:1618-1627. (Pubitemid 41324524)
69. Sieveking DP, Buckle A, Celermajer DS, et al. Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. J Am Coll Cardiol. 2008;51:660-668. (Pubitemid 351186872)
70. Kebir A, Harhouri K, Guillet B, et al. CD146 short isoform increases the proangiogenic potential of endothelial progenitor cells in vitro and in vivo. Circ Res. 2010;107:66-75.
71. Yao Y, Li Y, Ma G, et al. In vivo magnetic resonance imaging of injected endothelial progenitor cells after myocardial infarction in rats. Mol Imaging Biol. 2011;13:303-313.
72. Koga M, Sudo R, Abe Y, et al. Contribution of rat endothelial progenitor cells on three-dimensional network formation in vitro. Tissue Eng Part A. 2009;15:2727-2739.
73. Zhu S, Malhotra A, Zhang L, et al. Human umbilical cord blood endothelial progenitor cells decrease vein graft neointimal hyperplasia in SCID mice. Atherosclerosis. 2010;212:63-69.
74. Dubois C, Liu X, Claus P, et al. Differential effects of progenitor cell populations on left ventricular remodeling and myocardial neovascularization after myocardial infarction. J Am Coll Cardiol. 2010;55:2232-2243.
75. Hinkel R, El-Aouni C, Olson T, et al. Thymosin beta4 is an essential paracrine factor of embryonic endothelial progenitor cell-mediated cardioprotection. Circulation. 2008;117:2232-2240.
76. Hinkel R, Bock-Marquette I, Hatzopoulos AK, et al. Thymosin beta4: a key factor for protective effects of eEPCs in acute and chronic ischemia. Ann N Y Acad Sci. 2010;1194:105-111.
77. Kupatt C, Bock-Marquette I, Boekstegers P. Embryonic endothelial progenitor cell-mediated cardioprotection requires Thymosin beta4. Trends Cardiovasc Med. 2008;18:205-210.
78. Scheubel RJ, Holtz J, Friedrich I, et al. Paracrine effects of CD34 progenitor cells on angiogenic endothelial sprouting. Int J Cardiol. 2010; 139:134-141.
79. Smadja DM, Bieche I, Susen S, et al. Interleukin 8 is differently expressed and modulated by PAR-1 activation in early and late endothelial progenitor cells. J Cell Mol Med. 2009;13:2534-2546.
80. Wang SH, Lin SJ, Chen YH, et al. Late outgrowth endothelial cells derived from Wharton jelly in human umbilical cord reduce neointimal formation after vascular injury: involvement of pigment epitheliumderived factor. Arterioscler Thromb Vasc Biol. 2009;29:816-822.
81. Kim JY, Song SH, Kim KL, et al. Human cord blood-derived endothelial progenitor cells and their conditioned media exhibit therapeutic equivalence for diabetic wound healing. Cell Transplant. 2010;19: 1635-1644.
82. Lee MJ, Kim J, Lee KI, et al. Enhancement of wound healing by secretory factors of endothelial precursor cells derived from human embryonic stem cells. Cytotherapy. 2011;13:165-178.
83. Zhang Y, Ingram DA, Murphy MP, et al. Release of proinflammatory mediators and expression of proinflammatory adhesion molecules by endothelial progenitor cells. Am J Physiol Heart Circ Physiol. 2009; 296:H1675-H1682.
84. Grunewald M, Avraham I, Dor Y, et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell. 2006;124:175-189. (Pubitemid 43069318)
85. Tan Q, Qiu L, Li G, et al. Transplantation of healthy but not diabetic outgrowth endothelial cells could rescue ischemic myocardium in diabetic rabbits. Scand J Clin Lab Invest. 2010;70:313-321.
86. Yamaguchi J, Kusano KF, Masuo O, et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation. 2003;107: 1322-1328. (Pubitemid 36314418)
87. Palange P, Testa U, Huertas A, et al. Circulating haemopoietic and endothelial progenitor cells are decreased in COPD. Eur Respir J. 2006;27:529-541. (Pubitemid 43372527)
88. Capoccia BJ, Gregory AD, Link DC. Recruitment of the inflammatory subset of monocytes to sites of ischemia induces angiogenesis in a monocyte chemoattractant protein-1-dependent fashion. J Leukoc Biol. 2008;84:760-768.
89. Hattori K, Dias S, Heissig B, et al. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med. 2001;193: 1005-1014. (Pubitemid 32436194)
90. Suriano R, Chaudhuri D, Johnson RS, et al. 17Beta-estradiol mobilizes bone marrow-derived endothelial progenitor cells to tumors. Cancer Res. 2008;68:6038-6042.
91. Grote K, Salguero G, Ballmaier M, et al. The angiogenic factor CCN1 promotes adhesion and migration of circulating CD34+ progenitor cells: potential role in angiogenesis and endothelial regeneration. Blood. 2007;110:877-885. (Pubitemid 47267424)
92. Yu Y, Gao Y, Wang H, et al. The matrix protein CCN1 (CYR61) promotes proliferation, migration and tube formation of endothelial progenitor cells. Exp Cell Res. 2008;314:3198-3208.
93. Jiang H, Chen SS, Yang J, et al. CREB-binding protein silencing inhibits thrombin-induced endothelial progenitor cells angiogenesis. Mol Biol Rep. 2011. [Epub ahead of print].
94. Oh HK, Ha JM, O E, et al. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2. Cancer Res. 2007; 67:4851-4859. (Pubitemid 46915312)
95. Wu Y, Dai J, Schmuckler NG, et al. Cleaved high molecular weight kininogen inhibits tube formation of endothelial progenitor cells via suppression of matrix metalloproteinase 2. J Thromb Haemost. 2010; 8:185-193.
96. Nan JL, Li JJ, He JG. C-reactive protein decreases interleukin-8 production in human endothelial progenitor cells by inhibition of p38 MAPK pathway. Chin Med J (Engl). 2009;122:1922-1928.
97. Heida NM, Muller JP, Cheng IF, et al. Effects of obesity and weight loss on the functional properties of early outgrowth endothelial progenitor cells. J Am Coll Cardiol. 2010;55:357-367.
98. Hermansen SE, Lund T, Kalstad T, et al. Adrenomedullin augments the angiogenic potential of late outgrowth endothelial progenitor cells. Am J Physiol Cell Physiol. 2011;300:C783-C791.
99. Opitz CA, Rimmerman N, Zhang Y, et al. Production of the endocannabinoids anandamide and 2-arachidonoylglycerol by endothelial progenitor cells. FEBS Lett. 2007;581:4927-4931. (Pubitemid 47531770)
100. Khoo CP, Pozzilli P, Alison MR. Endothelial progenitor cells and their potential therapeutic applications. Regen Med. 2008;3:863-876.
101. Yang Z, Di Santo S, Kalka C. Current developments in the use of stem cell for therapeutic neovascularisation: is the future therapy "cell- free"? Swiss Med Wkly. 2010;140:w13130.
102. Popa ER, van der Strate BW, Brouwer LA, et al. Dependence of neovascularization mechanisms on the molecular microenvironment. Tissue Eng. 2007;13:2913-2921. (Pubitemid 350233074)
103. Gnecchi M, Zhang Z, Ni A, et al. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res. 2008;103:1204-1219.
104. Hao X, Silva EA, Mansson-Broberg A, et al. Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction. Cardiovasc Res. 2007;75: 178-185. (Pubitemid 46876668)
105. Okada H, Doken Y, Ogawa Y, et al. Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers. Pharm Res. 1994;11:1143-1147. (Pubitemid 24259854)
106. Redhead HM, Davis SS, Illum L. Drug delivery in poly(lactide-coglycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation. J Control Release. 2001;70:353-363. (Pubitemid 32155458)
107. Roy R, Zhang B, Moses MA. Making the cut: protease-mediated regulation of angiogenesis. Exp Cell Res. 2006;312:608-622. (Pubitemid 43290337)
108. Ehrbar M, Djonov VG, Schnell C, et al. Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth. Circ Res. 2004;94:1124-1132. (Pubitemid 38579708)
109. Murasawa S, Asahara T. Gene modified cell transplantation for vascular regeneration. Curr Gene Ther. 2007;7:1-6. (Pubitemid 46322285)
110. George J, Afek A, Abashidze A, et al. Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol. 2005;25:2636-2641. (Pubitemid 43732290)
111. Breitbach M, Bostani T, Roell W, et al. Potential risks of bone marrow cell transplantation into infarcted hearts. Blood. 2007;110:1362-1369. (Pubitemid 47281438)
112. Charo IF, Taubman MB. Chemokines in the pathogenesis of vascular disease. Circ Res. 2004;95:858-866. (Pubitemid 39435000)
113. Cheng M, Li Y, Wu J, et al. IL-8 induces imbalances between nitric oxide and endothelin-1, and also between plasminogen activator inhibitor- 1 and tissue-type plasminogen activator in cultured endothelial cells. Cytokine. 2008;41:9-15.
114. Naik RP, Jin D, Chuang E, et al. Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancer. Breast Cancer Res Treat. 2008;107:133-138. (Pubitemid 350179580)